Research shows the new drug bivalirudin does a better job at preventing clot formation during balloon angioplasty for severe heart attacks -- reducing the risk of death by one-third -- than current treatments. A second study also found using drugs that dissolve clots instead of preventing them does not improve survival and doubles the risk of major bleeding. The studies could slightly change the way ER physicians treat heart attacks.

Related Summaries